DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 121 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,165,000 | -26.8% | 219,800 | -26.9% | 0.09% | -24.4% |
| Q1 2021 | $2,957,000 | +415.2% | 300,800 | +133.3% | 0.12% | +324.1% |
| Q4 2020 | $574,000 | +3.1% | 128,912 | 0.0% | 0.03% | -21.6% |
| Q3 2020 | $557,000 | -93.1% | 128,912 | -85.7% | 0.04% | -94.0% |
| Q2 2020 | $8,025,000 | -21.1% | 904,479 | -68.6% | 0.62% | -48.1% |
| Q1 2020 | $10,174,000 | -50.0% | 2,882,036 | -19.0% | 1.19% | -38.3% |
| Q4 2019 | $20,361,000 | +70.2% | 3,559,547 | +6.4% | 1.93% | +69.9% |
| Q3 2019 | $11,960,000 | +129.6% | 3,345,346 | +156.3% | 1.14% | +136.2% |
| Q2 2019 | $5,208,000 | – | 1,305,346 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |